The US Food and Drug Administration approved drugmaker Novo Nordisk’s application to add cardiovascular benefits to the medicine’s label, making it the first weight-loss drug to also be ...

Researchers combined data on nearly 4,000 patients across four trials who had heart failure with preserved ejection fraction (or HFpEF) and found that 5.4% of those treated with Wegovy experienced ...

A GlaxoSmithKline (NYSE:GSK) drug used to combat nausea in cancer patients can cause an irregular heart rhythm in certain doses, according to a safety alert from the U.S. Food and Drug ...